| State of disease | P | ||||
| No relapse | relapsed | ||||
| No | % | No | % | ||
| LMR <2.8 ≥2.8 | 5 | 5.0% | 37 | 94.9% | <0.001 |
| 95 | 95.0% | 2 | 5.1% | ||
| ALC <1170 ≥1170 | 5 | 5.0% | 33 | 84.6% | <0.001 |
| 95 | 95.0% | 6 | 15.4% | ||
| AMC <445 ≥445 | 92 | 92.0% | 8 | 20.5% | <0.001 |
| 8 | 8.0% | 31 | 79.5% | ||
| LDH Normal >normal | 75 | 75.0% | 16 | 41.0% | <0.001* |
| 25 | 25.0% | 23 | 59.0% | ||
| ECOG ≤1 2 | 86 | 86% | 28 | 71.8% | 0.08 |
| 14 | 14% | 11 | 28.2% | ||
| Number of extra-sites <1 ≥1 | 52 | 52% | 11 | 28.2% | 0.01* |
| 48 | 48% | 28 | 71.8% | ||
| Stage Stage I-II Stage III-IV | 38 | 38% | 7 | 18% | 0.02* |
| 62 | 62% | 32 | 82% | ||
| IPI2 ≤1 >1 | 33 | 33% | 2 | 5.1% | 0.001* |
| 67 | 67% | 37 | 94.9% | ||
| Treatment R-CHOP CHOP | 32 | 32.0% | 3 | 7.7% | 0.003 |
| 68 | 68.0% | 36 | 92.3% | ||